Study reveals safe mannitol dosing for brain injury patients
NCT ID NCT06846307
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how different amounts of mannitol, a medicine used to reduce brain swelling, change blood osmolarity (a measure of blood thickness) in people with traumatic brain injury. Researchers observed 64 patients aged 18-40 with mild to moderate head injuries. The goal was to find safer ways to use mannitol by understanding its effect on the blood.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. Kariadi Central General Hospital
Semarang, Central Java, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart pump prevent dangerous drops in blood pressure during C-Sections?
- Spinal zaps could reboot breathing after brain injury
- Can a ketamine boost during surgery slash opioid needs?
- Can a wearable glucose sensor survive the operating room?
- Could music be medicine for the injured brain?
- Can blood markers predict brain injury outcomes?